Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer

2.

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

3.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

4.

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

5.

Research uncovers hidden Australian skin cancer epidemic


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot